EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Evaluation of Blood Product Wastage Rates and Causes

Neryal Tahta, Yeşim Oymak, Fahri Yüce Ayhan, Sultan Okur Acar, Salih Gözmen, Tuba Hilkay Karapınar, Melek Erdem, Işık Odaman Al, Raziye Canan Vergin

Cerrahpaşa Medical Journal · 23.03.2026 · 50 · 1-4

DOI: 10.5152/cjm.2026.25087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cerrahpaşa Medical Journal, online erschienen am 23.03.2026. Verfasst von Neryal Tahta und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Blood and blood components are valuable therapeutic products, particularly in pediatric settings where transfusion demand is variable and often urgent. Minimizing blood product wastage is essential to protect limited resources and ensure patient safety. The aim was to determine the rate, causes, and clinical distribution of blood product wastage in a tertiary pediatric hospital over a 1-year period.

Methods

This retrospective descriptive study reviewed all red blood cell concentrates (RBCC), apheresis platelet concentrates (APC), fresh frozen plasma (FFP), and cryoprecipitate processed in 2018. Wastage was defined as any allocated but unused unit that became unsuitable for transfusion. Reasons for discard and requesting clinical departments were analyzed.

Results

A total of 9 750 components were prepared; 73 (0.75%) were discarded. The wastage rates were RBCC 0.38%, APC 0.54%, FFP 1.8%, and cryoprecipitate 0.6%. The leading discard cause was expiration of shelf life (44%), followed by inappropriate requests (7%) and technical issues such as leakage or hemolysis (6%). Intensive care and emergency units accounted for the highest proportion of wastage.

Conclusion

Although the overall wastage rate was low, most losses were preventable. Implementing real-time electronic inventory tools, clinician education, and improved ordering–transfusion synchronization may further reduce wastage and enhance transfusion safety in pediatric care. Cite this article as: Tahta N, Oymak Y, Ayhan FY, et al. Evaluation of blood product wastage rates and causes. Cerrahpaşa Med J 2026, 50, 0087, doi: 10.5152/cjm.2026.25087.

Zitieren

APA

Tahta, N., Oymak, Y., Ayhan, F. Y., Acar, S. O., Gözmen, S., Karapınar, T. H., Erdem, M., Al, I. O., & Vergin, R. C. (2026). Evaluation of Blood Product Wastage Rates and Causes. Cerrahpaşa Medical Journal, 50, 1-4. https://doi.org/10.5152/cjm.2026.25087

Vancouver

Tahta N, Oymak Y, Ayhan FY, Acar SO, Gözmen S, Karapınar TH, et al. Evaluation of Blood Product Wastage Rates and Causes. Cerrahpaşa Medical Journal. 2026;50:1-4. doi:10.5152/cjm.2026.25087

BibTeX
@article{Tahta2026,
  author = {Tahta, Neryal and Oymak, Yeşim and Ayhan, Fahri Yüce and Acar, Sultan Okur and Gözmen, Salih and Karapınar, Tuba Hilkay and Erdem, Melek and Al, Işık Odaman and Vergin, Raziye Canan},
  title = {Evaluation of Blood Product Wastage Rates and Causes},
  journal = {Cerrahpaşa Medical Journal},
  year = {2026},
  volume = {50},
  pages = {1--4},
  doi = {10.5152/cjm.2026.25087}
}
Kostenlos starten →